Clear Harbor Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-18,094
| Closed | -$195K | – | 261 |
|
2017
Q2 | $195K | Buy |
18,094
+16,264
| +889% | +$175K | 0.04% | 232 |
|
2017
Q1 | $44K | Sell |
1,830
-305
| -14% | -$7.33K | 0.01% | 244 |
|
2016
Q4 | $69K | Sell |
2,135
-26
| -1% | -$840 | 0.01% | 238 |
|
2016
Q3 | $108K | Sell |
2,161
-165
| -7% | -$8.25K | 0.02% | 230 |
|
2016
Q2 | $99K | Sell |
2,326
-38
| -2% | -$1.62K | 0.02% | 242 |
|
2016
Q1 | $156K | Sell |
2,364
-6
| -0.3% | -$396 | 0.03% | 224 |
|
2015
Q4 | $147K | Sell |
2,370
-255
| -10% | -$15.8K | 0.03% | 233 |
|
2015
Q3 | $176K | Buy |
2,625
+32
| +1% | +$2.15K | 0.04% | 238 |
|
2015
Q2 | $252K | Hold |
2,593
| – | – | 0.05% | 239 |
|
2015
Q1 | $242K | Hold |
2,593
| – | – | 0.05% | 240 |
|
2014
Q4 | $231K | Sell |
2,593
-38
| -1% | -$3.39K | 0.05% | 244 |
|
2014
Q3 | $182K | Buy |
2,631
+89
| +4% | +$6.16K | 0.04% | 197 |
|
2014
Q2 | $146K | Buy |
+2,542
| New | +$146K | 0.03% | 203 |
|